Past catalysts on this ticker, reconciled against the announcement parse pipeline. Hover any row for the parsed outcome detail.
RECCE 327's own upcoming catalysts alongside class-defining historical readouts and upcoming primary completion dates in the same mechanism classes. Each event moves the broader thesis for RECCE 327. Showing past 6 months and next 12 months · 8 later hidden.
Same axes, same units. Discontinued and historical pivotal trials excluded; see Competitor Landscape below for the full set.
| Trial | Sponsor | Class | Phase / Line | Design | Primary endpoint | Dosing | Key eligibility | n |
|---|---|---|---|---|---|---|---|---|
| RECCE 327 | Recce Pharmaceuticals | Synthetic polymer antibiotic | Preclinical | 0 | ||||
| An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures | University of Santiago de Compostela | — |
Read-across commentary attached per trial. Phase ordering preserved within each group.
External analyst notes, journalism, and industry commentary cited with attribution.
"Sponsor guided" dates come from IR materials and earnings calls; hover for the cited source. "CT.gov proxy" dates fall back to the registry primary completion date — actual readouts typically follow by 3-6 months.
| — |
| — |
| — |
| — |
| — |
| Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | — | Phase 4 | — | — | — | — | — |
| Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) | Murdoch Childrens Research Institute | — | Phase 4 | — | — | — | — | — |
| Therapeutic Options for CRAB | Clinical Hospital Centre Zagreb | — | Phase 4 | — | — | — | — | — |
| PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) | Rambam Health Care Campus | — | Phase 4 | — | — | — | — | — |
| Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia | Mahidol University | — | Phase 4 | — | — | — | — | — |
| Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia | Region Skane | — | Phase 4 | — | — | — | — | — |
| Optimising TREATment for Severe Gram-Negative Bacterial Infections | National University of Singapore | — | Phase 4 | — | — | — | — | — |
| Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia | Clinical Research Centre, Malaysia | — | Phase 3 | — | — | — | — | — |
| Management of Shock in Children With SAM or Severe Underweight and Diarrhea | International Centre for Diarrhoeal Disease Research, Bangladesh | — | Phase 3 | — | — | — | — | — |
| Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus | Assistance Publique - Hôpitaux de Paris | — | Phase 3 | — | — | — | — | — |
| Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation | Mundipharma Research Limited | — | Phase 3 | — | — | — | — | — |
| Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections | Qilu Pharmaceutical Co., Ltd. | — | Phase 3 | — | — | — | — | — |
| A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections | Angela HUTTNER | — | Phase 3 | — | — | — | — | — |
| Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates | Indian Council of Medical Research | — | Phase 3 | — | — | — | — | — |
| A Randomized Study of a Short Duration Therapy for Candidemia | Assistance Publique - Hôpitaux de Paris | — | Phase 3 | — | — | — | — | — |
| Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs | Lund University | — | Phase 3 | — | — | — | — | — |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | Basilea Pharmaceutica | — | Phase 3 | — | — | — | — | — |
| STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis | University of Virginia | — | Phase 3 | — | — | — | — | — |
| A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women | Minervax ApS | — | PHASE2/PHASE3 | — | — | — | — | — |
| Pentaglobin in CRE and PA Neutropenic Infections | Gruppo Italiano Trapianto di Midollo Osseo | — | Phase 2 | — | — | — | — | — |
| Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia | Todd C. Lee MD MPH FIDSA | — | Phase 2 | — | — | — | — | — |
| Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia | Radboud University Medical Center | — | Phase 2 | — | — | — | — | — |
| Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex | BioVersys AG | — | Phase 2 | — | — | — | — | — |
| A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa) | AstraZeneca | — | PHASE1/PHASE2 | — | — | — | — | — |